Target intelligence / Profile preview

Pathogenic oral and intestinal bacterium (null)

Target
null
Molecular classification
Other (heterogeneous group of Gram-positive and Gram-negative bacteria), Pathogen (not a molecular classification, but a functional grouping)
01

Overview

"Pathogenic oral and intestinal bacteria" is a general term encompassing numerous **disease-associated bacterial species** that colonize the human oral cavity and intestinal tract. Key oral pathogens include *Fusobacterium nucleatum*, *Porphyromonas gingivalis*, *Aggregatibacter actinomycetemcomitans*, *Treponema denticola*, *Streptococcus mutans*, and others, while notable intestinal pathogens overlap with oral ones and may include *Enterobacteriaceae*, *Bacteroides*, and *Clostridium* species[1][2][3]. These bacteria contribute to local diseases such as dental caries, periodontitis, and gastrointestinal infections, but also systemic conditions including inflammatory bowel disease, colorectal and gastric cancers, cardiovascular and neurodegenerative diseases[1][2][3]. They are targets for antimicrobial therapy as a functional group, but the term does not denote a single, well-defined molecular drug target or receptor. For structured drug target data, refer to individual species, their surface proteins, or specific virulence factors rather than this nonspecific grouping.

Other names
Pathogenic oral bacteriaPathogenic intestinal bacteriaOral pathogensIntestinal pathogensOral-gut disease-associated bacteria
02

Mechanism of action

Disruption of bacterial cell wall or membrane integrity (as with beta-lactams, chlorhexidine) Inhibition of protein, DNA, or metabolic pathways (antibiotics) Bacterial population modulation (e.g., probiotics) Lytic activity (bacteriophages)

03

Biological functions

Infection and host colonizationImmune evasionBiofilm formationTissue invasionModulating inflammatory responseMetabolite/toxin production (e.g., volatile sulfur compounds, acids)
04

Disease associations

Infection (e.g., dental caries, periodontitis, gastrointestinal infections)Inflammation (e.g., inflammatory bowel disease)Cancer (e.g., colorectal cancer, oral and gastric cancers)Systemic diseases (e.g., cardiovascular disease, rheumatoid arthritis, neurodegeneration)
05

Safety considerations

Antimicrobial resistanceMicrobiome dysbiosis following broad-spectrum antibiotic useOpportunistic infections and overgrowth by resistant or non-target speciesDisruption of beneficial commensal bacteria leading to increased risk of other diseases
06

Interacting drugs

Broad-spectrum antibiotics (e.g., amoxicillin, metronidazole, clindamycin)

4 more in the full profile.

07

Biomarkers

16S rRNA gene signals for specific species (e.g., *Fusobacterium nucleatum*, *Porphyromonas gingivalis*)Volatile sulfur compounds (for halitosis/periodontal disease)Specific bacterial DNA or metabolites detected in saliva, plaque, or stool

Beyond the preview

Go deeper on Pathogenic oral and intestinal bacterium (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic oral and intestinal bacterium (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call